CVS - CVS Health Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$100.33
DETAILS
HIGH:
$110.00
LOW:
$90.00
MEDIAN:
$101.00
CONSENSUS:
$100.33
UPSIDE:
7.58%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 792,400 | $56.9M | 0.0% | -1,081,100 | DECREASED |
| Dalio | 618,428 | $44.4M | 0.2% | -418,924 | DECREASED |
| Greenblatt | 196,104 | $14.1M | 0.0% | -103,401 | DECREASED |
| Wood | 71,700 | $5.1M | 0.0% | -247,800 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-20 | AGUIRRE FERNANDO | director | D-Return | 30,437 | $93.78 | $2.9M |
| 2026-05-21 | AGUIRRE FERNANDO | director | D-Return | 1,563 | $93.50 | $146K |
| 2026-05-21 | ROBBINS LARRY | director | SELL | 378,000 | $58.29 | $22.0M |
| 2026-05-20 | ROBBINS LARRY | director | SELL | 66,881 | $95.67 | $6.4M |
| 2026-05-19 | ROBBINS LARRY | director | SELL | 1,983,387 | $94.45 | $187.3M |
| 2026-05-19 | ROBBINS LARRY | director | SELL | 151 | $95.18 | $14K |
| 2026-05-20 | ROBBINS LARRY | director | SELL | 797,628 | $93.48 | $74.6M |
| 2026-05-20 | ROBBINS LARRY | director | SELL | 152,691 | $94.81 | $14.5M |
| 2026-05-21 | ROBBINS LARRY | director | SELL | 370,462 | $93.45 | $34.6M |
| 2026-05-20 | ROBBINS LARRY | director | SELL | 800 | $96.28 | $77K |
| 2026-05-14 | Gallina John E | director | A-Award | 1,447 | -- | -- |
| 2026-05-14 | Mahoney Michael F | director | A-Award | 1,737 | -- | -- |
| 2026-05-14 | AGUIRRE FERNANDO | director | A-Award | 1,563 | $97.15 | $152K |
| 2026-05-14 | KIRBY J SCOTT | director | A-Award | 1,447 | $97.15 | $141K |
| 2026-05-14 | Norwalk Leslie V | director | A-Award | 1,447 | $97.15 | $141K |
| 2026-05-14 | DECOUDREAUX ALECIA A | director | A-Award | 1,447 | -- | -- |
| 2026-05-14 | BROWN C DAVID II | director | A-Award | 1,544 | $97.15 | $150K |
| 2026-05-14 | Shulman Douglas H. | director | A-Award | 1,447 | -- | -- |
| 2026-05-14 | ROBBINS LARRY | director | A-Award | 1,930 | -- | -- |
| 2026-05-14 | Finucane Anne A. | director | A-Award | 1,544 | -- | -- |
| 2026-05-14 | SANSONE GUY P | director | A-Award | 1,447 | $97.15 | $141K |
| 2026-05-14 | Balser Jeffrey R. | director | A-Award | 2,058 | $97.15 | $200K |
| 2026-05-08 | Mandadi Tilak | officer: EVP, Chief Exp & Tech Officer | SELL | 69,551 | $89.58 | $6.2M |
| 2026-04-01 | Nelson Steven H | officer: EVP and President, Aetna | F-InKind | 2,432 | $72.49 | $176K |
| 2026-04-01 | Clark James David | officer: SVP, Cont & Chief Acct Officer | F-InKind | 3,262 | $72.49 | $236K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-05-18 | Dwight Evans | HOUSE | Sale | $1,001 - $15,000 |
| 2026-05-15 | Dwight Evans | HOUSE | Sale (Partial) | $1,001 - $15,000 |
| 2026-05-13 | Ro Khanna | HOUSE | Purchase | $1,001 - $15,000 |